Fetal Sex Determination From Maternal Plasma in Pregnancies at Risk for Congenital Adrenal Hyperplasia

Robbert J. P. Rijnders; C. Ellen van der Schoot; Bernadette Bossers; Monique A. M. J. de Vroede; Godelieve C. M. L. Christiaens

doi:10.1097/00006250-200109000-00003

Fetal Sex Determination From Maternal Plasma in Pregnancies at Risk for Congenital Adrenal Hyperplasia

Obstetrics and Gynecology ◽

10.1097/00006250-200109000-00003 ◽

2001 ◽

Vol 98 (3) ◽

pp. 374-378 ◽

Cited By ~ 3

Author(s):

Robbert J. P. Rijnders ◽

C. Ellen van der Schoot ◽

Bernadette Bossers ◽

Monique A. M. J. de Vroede ◽

Godelieve C. M. L. Christiaens

Keyword(s):

At Risk ◽

Congenital Adrenal Hyperplasia ◽

Sex Determination ◽

Maternal Plasma ◽

Adrenal Hyperplasia ◽

Fetal Sex

Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia

Obstetrics and Gynecology ◽

10.1016/s0029-7844(01)01480-6 ◽

2001 ◽

Vol 98 (3) ◽

pp. 374-378 ◽

Cited By ~ 63

Author(s):

R Rijnders

Keyword(s):

At Risk ◽

Congenital Adrenal Hyperplasia ◽

Sex Determination ◽

Maternal Plasma ◽

Adrenal Hyperplasia ◽

Fetal Sex

Faculty Opinions recommendation of New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718255870.793490448 ◽

2014 ◽

Author(s):

Phyllis Speiser

Keyword(s):

At Risk ◽

Congenital Adrenal Hyperplasia ◽

Sex Determination ◽

Management Strategy ◽

Maternal Serum ◽

Adrenal Hyperplasia ◽

Fetal Sex ◽

French Cohort

New Management Strategy of Pregnancies at Risk of Congenital Adrenal Hyperplasia Using Fetal Sex Determination in Maternal Serum: French Cohort of 258 Cases (2002–2011)

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2013-2895 ◽

2014 ◽

Vol 99 (4) ◽

pp. 1180-1188 ◽

Cited By ~ 49

Author(s):

Véronique Tardy-Guidollet ◽

Rita Menassa ◽

Jean-Marc Costa ◽

Michel David ◽

Claire Bouvattier-Morel ◽

...

Keyword(s):

At Risk ◽

Congenital Adrenal Hyperplasia ◽

Sex Determination ◽

Management Strategy ◽

Maternal Serum ◽

Adrenal Hyperplasia ◽

Fetal Sex ◽

French Cohort

Faculty Opinions recommendation of Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717747955.793508335 ◽

2015 ◽

Author(s):

Phyllis Speiser

Keyword(s):

At Risk ◽

Congenital Adrenal Hyperplasia ◽

Children At Risk ◽

Adrenal Hyperplasia ◽

Dexamethasone Treatment ◽

Swedish Experience

Faculty Opinions recommendation of Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia--a pilot study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9187957.9779055 ◽

2011 ◽

Author(s):

Phyllis Speiser

Keyword(s):

At Risk ◽

Pilot Study ◽

Gender Role ◽

Congenital Adrenal Hyperplasia ◽

Children At Risk ◽

Adrenal Hyperplasia

Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jcem.76.1.8421074 ◽

1993 ◽

Vol 76 (1) ◽

pp. 117-120

Author(s):

H G Dörr ◽

W G Sippell

Keyword(s):

At Risk ◽

Amniotic Fluid ◽

Congenital Adrenal Hyperplasia ◽

Adrenal Hyperplasia ◽

Dexamethasone Treatment ◽

Hydroxylase Deficiency ◽

21 Hydroxylase Deficiency

Efficacy and safety of prenatal dexamethasone treatment in offspring at risk for congenital adrenal hyperplasia due to 21‐hydroxylase deficiency: A systematic review and meta‐analysis

Clinical Endocrinology ◽

10.1111/cen.14126 ◽

2019 ◽

Vol 92 (2) ◽

pp. 109-123 ◽

Cited By ~ 1

Author(s):

Lizhen Xu ◽

Wei Lin ◽

Liangchun Cai ◽

Huibin Huang ◽

Jixing Liang ◽

...

Keyword(s):

Systematic Review ◽

At Risk ◽

Congenital Adrenal Hyperplasia ◽

Meta Analysis ◽

Efficacy And Safety ◽

Adrenal Hyperplasia ◽

Dexamethasone Treatment ◽

Hydroxylase Deficiency ◽

21 Hydroxylase Deficiency

Prenatal treatment of mothers with fetuses at risk for congenital adrenal hyperplasia: How relevant is it to Indian context?

Indian Journal of Endocrinology and Metabolism ◽

10.4103/2230-8210.111596 ◽

2013 ◽

Vol 17 (3) ◽

pp. 373 ◽

Cited By ~ 4

Author(s):

AriacheryC Ammini ◽

Marumudi Eunice

Keyword(s):

At Risk ◽

Congenital Adrenal Hyperplasia ◽

Prenatal Treatment ◽

Adrenal Hyperplasia ◽

Indian Context

Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency

Obstetrics and Gynecology ◽

10.1016/s0029-7844(03)00064-4 ◽

2003 ◽

Vol 101 (5) ◽

pp. 1135-1136 ◽

Cited By ~ 22

Author(s):

J BARTHA

Keyword(s):

At Risk ◽

Sex Determination ◽

Maternal Blood ◽

Hydroxylase Deficiency ◽

Fetal Sex ◽

21 Hydroxylase Deficiency

Reliability of Fetal Sex Determination Using Maternal Plasma

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(10)79373-5 ◽

2010 ◽

Vol 2010 ◽

pp. 44-45

Author(s):

J.S. Dungan

Keyword(s):

Sex Determination ◽

Maternal Plasma ◽

Fetal Sex